ArmonAir RespiClick Interactions
There are 112 drugs known to interact with ArmonAir RespiClick (fluticasone), along with 6 disease interactions. Of the total drug interactions, 37 are major, 59 are moderate, and 16 are minor.
- View all 112 medications that may interact with ArmonAir RespiClick
- View ArmonAir RespiClick disease interactions (6)
Most frequently checked interactions
View interaction reports for ArmonAir RespiClick (fluticasone) and the medicines listed below.
- aclidinium
- Advair Diskus (fluticasone / salmeterol)
- Advair HFA (fluticasone / salmeterol)
- AirDuo Respiclick (fluticasone / salmeterol)
- Alvesco (ciclesonide)
- Anoro Ellipta (umeclidinium / vilanterol)
- Arcapta (indacaterol)
- Asmanex HFA (mometasone)
- Asmanex Twisthaler (mometasone)
- Atrovent HFA (ipratropium)
- beractant
- Bethkis (tobramycin)
- Bevespi Aerosphere (formoterol / glycopyrrolate)
- Breo Ellipta (fluticasone / vilanterol)
- Cayston (aztreonam)
- ciclesonide
- Cinqair (reslizumab)
- colistimethate
- Combivent (albuterol / ipratropium)
- Combivent Respimat (albuterol / ipratropium)
- Daliresp (roflumilast)
- dornase alfa
- Dulera (formoterol / mometasone)
- Fasenra (benralizumab)
- ProAir RespiClick (albuterol)
- Qvar RediHaler (beclomethasone)
- Spiriva Respimat (tiotropium)
- Stiolto Respimat (olodaterol / tiotropium)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Utibron Neohaler (glycopyrrolate / indacaterol)
ArmonAir RespiClick disease interactions
There are 6 disease interactions with ArmonAir RespiClick (fluticasone) which include:
- hepatic impairment
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
- hyperadrenocorticism
Report options
QR code containing a link to this page
More about ArmonAir RespiClick (fluticasone)
- ArmonAir RespiClick consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: inhaled corticosteroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.